(Q36367915)

13 August 2017

1 reference

title

On the diagnosis of erythrodermic cutaneous T-cell lymphoma (English)

1 reference

13 August 2017

Eric C Vonderheid

1

1 reference

13 August 2017

1 February 2006

1 reference

Journal of Cutaneous Pathology

13 August 2017

1 reference

13 August 2017

33 Suppl 1

1 reference

13 August 2017

27-42

1 reference

Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Life-threatening erythroderma: diagnosing and treating the "red man".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Erythroderma. A clinical and follow-up study of 102 patients, with special emphasis on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Erythroderma: a clinico-etiologic study of 90 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Erythroderma: a comparison between HIV positive and negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Erythroderma in adults: a report of 80 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Erythroderma: a clinical study of 97 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Pre-Sézary erythroderma evolving to Sézary syndrome. A report of seven cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Ofuji papuloerythroderma evolving to cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Primary Sézary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Diagnosing erythrodermic cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Defining early mycosis fungoides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Accumulation of CD4+CD7- T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Improved sensitivity of T-cell clonality detection in mycosis fungoides by hand microdissection and heteroduplex analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Improved detection of clonality in cutaneous T-cell lymphomas using laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Correlations between clinical, histologic, blood, and skin polymerase chain reaction outcome in patients treated for mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Peripheral blood T-cell clonality in mycosis fungoides and nonlymphoma controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

The Sézary syndrome: hematologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Expression of V beta gene segments by Sezary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Pseudo-spikes are common in histologically benign lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Frédéric Woringer: Pautrier-Woringer disease (lipomelanotic reticulosis/dermatopathic lymphadenitis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Atypical cutaneous lymphoproliferative disorder in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Clinicopathological features of cutaneous lesions of adult T-cell leukaemia/ lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

T-cell prolymphocytic leukemia involving extramedullary sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

Lymphocytes with cerebriform nuclei in chronic B-cell lymphoproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2006.00541.X

10.1111/J.0303-6987.2006.00541.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16412210